The Clinical AI & RWD Leader

Products & Services
Research
Use Cases
About Us

THE LATEST IN PRESS & MEDIA COVERAGE

News

Media Coverage

June 5, 2019

Broader Inclusion Criteria Could Double The Number Of Patients With Lung Cancer Eligible for Clinical Trials

Press Release

June 3, 2019

ConcertAI Real World Data Used to Demonstrate Positive Impact of Broadened vs. Traditional Eligibility Criteria

Media Coverage

June 3, 2019

ASCO: ConcertAI uses real-world data to fill the research gap among patients excluded from NSCLC trials

Press Release

June 1, 2019

ConcertAI to Showcase 1st End-to-End RWD and AI Technology Framework for Life Sciences and RWE Solutions at ASCO 2019

Press Release

May 30, 2019

4 Research Abstracts Use ConcertAI RWD to Study Cancer Patients with Autoimmune Disease Frequently Excluded from Clinical Trials

Uncategorized

May 29, 2019

AI model to predict survival factors in lung cancer for better trial recruitment

Press Release

May 28, 2019

ConcertAI to Present AI Model for Predicting Survival of Lung Cancer Patients, with Wide-Ranging Uses for Clinical Development

Press Release

May 14, 2019

ConcertAI to Present AI Model for Identifying Metastatic Status of Cancer Patients with High Accuracy Using Structured EHR Data at ISPOR 2019

Media Coverage

May 7, 2019

AI takes on the world of medicament, influencing drug development

Media Coverage

April 12, 2019

Pfizer, ConcertAI join up for precision medicine partnership

Products & Services
Research
Use Cases
About Us

© 2017-2024 ConcertAI. All Rights Reserved. ConcertAI is a SymphonyAI company.

Privacy Policy Terms of Use